| Results suggest that miR-24 may function as a tumor suppressor in laryngeal squamous cell carcinoma through down-regulation of S100A8. | laryngeal, |
| miR-24 functions as a novel tumor suppressor in gastric cancer, and the anti-oncogenic activity may involve its inhibition of the target gene REG4. | gastric, |
| downregulation of the miR-23b/27b/24-1 cluster was a frequent event in prostate cancer, and these clustered miRNAs functioned as tumor suppressors | prostate, |
| These findings provide evidence that miR-24 has a tumor suppressor role in prostate cancer and also targets p27 and p16 in prostate cancer cells | prostate, |
| Study observed that plasma miR-21 was elevated in colorectal cancer (CRC); on the contrary, the miR-24 as a tumor suppressor miRNA might be suppressed gradually by tumor progression. Plasma ratio of miR-21/24 significantly correlated with several important prognosis factors in CRC, such as tumor size, TNM stage, lymph metastasis, histologic differentiation, and survival prognosis. | colorectal, |
| overexpression of DND1 could rescue the tumor suppressive effects of miR-24, indicating direct involvement of DND1 in the miR-24 mediated inhibitory effects on SW48 cell proliferation. The miR-24 acts as a tumor suppressor and may prove essential in the treatment of colorectal cancer (CRC) | colorectal, |
| These results suggest that miR-24-3p functions as a tumor suppressor and the miR-24-3p/p130Cas axis is a novel factor of cancer progression by regulating cell migration and invasion. | None |
| miR-24 functions as an oncogene in hepatocellular carcinoma, at least partly by promoting cell invasion through down-regulation of p53. | liver, |